These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 29049919)
1. Comparison of CHA Hu WS; Lin CL Atherosclerosis; 2017 Nov; 266():205-211. PubMed ID: 29049919 [TBL] [Abstract][Full Text] [Related]
2. Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study. Saliba W; Gronich N; Barnett-Griness O; Rennert G Am J Med; 2016 Aug; 129(8):843-9. PubMed ID: 27012854 [TBL] [Abstract][Full Text] [Related]
3. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809 [TBL] [Abstract][Full Text] [Related]
4. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation. Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940 [TBL] [Abstract][Full Text] [Related]
5. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452 [TBL] [Abstract][Full Text] [Related]
6. The CHADS Barkas F; Elisaf M; Korantzopoulos P; Tsiara S; Liberopoulos E Int J Cardiol; 2017 Aug; 241():194-199. PubMed ID: 28442233 [TBL] [Abstract][Full Text] [Related]
7. The Value of the CHADS Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449 [TBL] [Abstract][Full Text] [Related]
8. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219 [TBL] [Abstract][Full Text] [Related]
9. Role of CHA Hu WS; Lin CL BMJ Open; 2018 Mar; 8(3):e020065. PubMed ID: 29567851 [TBL] [Abstract][Full Text] [Related]
10. CHADS Wu JT; Wang SL; Chu YJ; Long DY; Dong JZ; Fan XW; Yang HT; Duan HY; Yan LJ; Qian P J Atheroscler Thromb; 2017 Feb; 24(2):176-184. PubMed ID: 27301462 [TBL] [Abstract][Full Text] [Related]
11. Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians? Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA Heart Rhythm; 2016 Jan; 13(1):46-53. PubMed ID: 26277496 [TBL] [Abstract][Full Text] [Related]
12. Prediction of new-onset atrial fibrillation after first-ever ischemic stroke: A comparison of CHADS Hsieh CY; Lee CH; Wu DP; Sung SF Atherosclerosis; 2018 May; 272():73-79. PubMed ID: 29571030 [TBL] [Abstract][Full Text] [Related]
13. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809 [TBL] [Abstract][Full Text] [Related]
14. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation. Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082 [TBL] [Abstract][Full Text] [Related]
15. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study. Hu WS; Lin CL Europace; 2018 Apr; 20(4):575-581. PubMed ID: 28407109 [TBL] [Abstract][Full Text] [Related]
16. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143 [TBL] [Abstract][Full Text] [Related]
18. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706 [TBL] [Abstract][Full Text] [Related]
19. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial. Apostolakis S; Lane DA; Buller H; Lip GY Thromb Haemost; 2013 Nov; 110(5):1074-9. PubMed ID: 24048467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]